Cargando…
Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study
This study aimed to prospectively evaluate, on a long-term basis, corneal side effects secondary to compassionate administration of epidermal growth factor receptor (EGFR) inhibitor depatuxizumab mafodotin (ABT-414) in patients affected by EGFR-amplified recurrent glioblastoma. Fifteen patients with...
Autores principales: | Parrozzani, Raffaele, Lombardi, Giuseppe, Midena, Edoardo, Londei, Davide, Padovan, Marta, Marchione, Giulia, Caccese, Mario, Midena, Giulia, Zagonel, Vittorina, Frizziero, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591744/ https://www.ncbi.nlm.nih.gov/pubmed/33154952 http://dx.doi.org/10.3389/fonc.2020.593461 |
Ejemplares similares
-
Corneal side effects induced by EGFR-inhibitor antibody–drug
conjugate ABT-414 in patients with recurrent glioblastoma: a prospective
clinical and confocal microscopy study
por: Parrozzani, Raffaele, et al.
Publicado: (2020) -
Chorioretinal Side Effects of Therapeutic Ocular Irradiation: A Multimodal Imaging Approach
por: Midena, Giulia, et al.
Publicado: (2020) -
In vivo intraocular biomarkers: Changes of aqueous humor cytokines and chemokines in patients affected by uveal melanoma
por: Midena, Edoardo, et al.
Publicado: (2020) -
Thrombocytopenia as Type 1 ROP Biomarker: A Longitudinal Study
por: Parrozzani, Raffaele, et al.
Publicado: (2021) -
Diabetic Macular Edema Treated with 577-nm Subthreshold Micropulse Laser: A Real-Life, Long-Term Study
por: Frizziero, Luisa, et al.
Publicado: (2021)